Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer
Status:
Suspended
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This is a phase II, open-label clinical study prospectively enrolling 40 metastatic patients
with non small cell lung cancer. The study will enroll patients at King Abdulaziz Medical
City, Riyadh.
Sub-sites will be open for patient accrual in selected centers in the Kingdom.